299 related articles for article (PubMed ID: 16298943)
21. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes.
Pan XQ; Wang H; Lee RJ
Anticancer Res; 2002; 22(3):1629-33. PubMed ID: 12168846
[TBL] [Abstract][Full Text] [Related]
22. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
23. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stephenson SM; Yang W; Stevens PJ; Tjarks W; Barth RF; Lee RJ
Anticancer Res; 2003; 23(4):3341-5. PubMed ID: 12926073
[TBL] [Abstract][Full Text] [Related]
24. Physical and tumor biological aspects and calculation model of dosage in boron neutron capture therapy (BNCT).
Rassow J; Pöller F; Steinberg F; Meissner P
Strahlenther Onkol; 1993 Jan; 169(1):7-17. PubMed ID: 8434343
[TBL] [Abstract][Full Text] [Related]
25. [Boron neutron capture therapy using 10B entrapped anti-CEA immunoliposome].
Yanagie H; Fujii Y; Takahashi T; Tomita T; Fukano Y; Hasumi K; Nariuchi H; Yasuda T; Sekiguchi M; Uchida H
Hum Cell; 1989 Sep; 2(3):290-6. PubMed ID: 2519218
[TBL] [Abstract][Full Text] [Related]
26. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
[TBL] [Abstract][Full Text] [Related]
27. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
Barth RF; Wu G; Yang W; Binns PJ; Riley KJ; Patel H; Coderre JA; Tjarks W; Bandyopadhyaya AK; Thirumamagal BT; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):899-903. PubMed ID: 15308165
[TBL] [Abstract][Full Text] [Related]
28. Sensitizing effect of the phosphatidylinositol 3-kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound.
Kinashi Y; Sakurai Y; Masunaga S; Takagaki M; Ono K
Radiat Med; 2001; 19(1):27-32. PubMed ID: 11305615
[TBL] [Abstract][Full Text] [Related]
29. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
Yang W; Wu G; Barth RF; Swindall MR; Bandyopadhyaya AK; Tjarks W; Tordoff K; Moeschberger M; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
Clin Cancer Res; 2008 Feb; 14(3):883-91. PubMed ID: 18245552
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study for application of anti-alpha-fetoprotein monoclonal antibody to boron-neutron capture therapy.
Takahashi T; Fujii Y; Fujii G; Nariuchi H
Jpn J Exp Med; 1987 Apr; 57(2):83-91. PubMed ID: 2444730
[TBL] [Abstract][Full Text] [Related]
32. Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture.
Laster BH; Kahl SB; Popenoe EA; Pate DW; Fairchild RG
Cancer Res; 1991 Sep; 51(17):4588-93. PubMed ID: 1873803
[TBL] [Abstract][Full Text] [Related]
33. Cell survival measurements in an argon, aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapy.
Mill AJ; Morgan GR; Newman SM
Br J Radiol; 1994 Oct; 67(802):1008-16. PubMed ID: 8000825
[TBL] [Abstract][Full Text] [Related]
34. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of growth of human breast cancer cells in culture by neutron capture using liposomes containing 10B.
Yanagië H; Kobayashi H; Takeda Y; Yoshizaki I; Nonaka Y; Naka S; Nojiri A; Shinnkawa H; Furuya Y; Niwa H; Ariki K; Yasuhara H; Eriguchi M
Biomed Pharmacother; 2002 Mar; 56(2):93-9. PubMed ID: 12000141
[TBL] [Abstract][Full Text] [Related]
36. Calibration of the borated ion chamber at NIST reactor thermal column.
Wang Z; Hertel NE; Lennox A
Radiat Prot Dosimetry; 2007; 126(1-4):626-30. PubMed ID: 17525059
[TBL] [Abstract][Full Text] [Related]
37. Biomedical applications of 10B and 11B NMR.
Bendel P
NMR Biomed; 2005 Apr; 18(2):74-82. PubMed ID: 15770608
[TBL] [Abstract][Full Text] [Related]
38. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
39. Concomitant boron-neutron capture therapy during fast-neutron irradiation of a rat glioma.
Buchholz TA; Rasey JS; Laramore GE; Livesey JC; Chin L; Risler R; Hamlin DK; Spence AM; Griffin TW
Radiology; 1994 Jun; 191(3):863-7. PubMed ID: 8184080
[TBL] [Abstract][Full Text] [Related]
40. Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies.
Wei Q; Kullberg EB; Gedda L
Int J Oncol; 2003 Oct; 23(4):1159-65. PubMed ID: 12963999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
